• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未经过治疗的成人急性髓系白血病伴中性粒细胞减少症发热患者强化化疗期间的肠道微生物群特征。

Gut microbiota profiles of treatment-naïve adult acute myeloid leukemia patients with neutropenic fever during intensive chemotherapy.

机构信息

Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

出版信息

PLoS One. 2020 Oct 28;15(10):e0236460. doi: 10.1371/journal.pone.0236460. eCollection 2020.

DOI:10.1371/journal.pone.0236460
PMID:33112882
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7592783/
Abstract

The intestinal bacterial flora of febrile neutropenic patients has been found to be significantly diverse. However, there are few reports of alterations of in adult acute myeloid leukemia (AML) patients. Stool samples of each treatment-naïve AML patient were collected the day before initiation of induction chemotherapy (pretreatment), on the first date of neutropenic fever and first date of bone marrow recovery. Bacterial DNA was extracted from stool samples and bacterial 16s ribosomal RNA genes were sequenced by next-generation sequencing. Relative abundance, overall richness, Shannon's diversity index and Simpson's diversity index were calculated. No antimicrobial prophylaxis was in placed in all participants. Ten cases of AML patients (4 male and 6 female) were included with a median age of 39 years (range: 19-49) and all of patients developed febrile neutropenia. Firmicutes dominated during the period of neutropenic fever, subsequently declining after bone marrow recovery a pattern in contrast to that shown by Bacteroidetes and Proteobacteria. Enterococcus was more abundant in the febrile neutropenia period compared to pretreatment (mean difference +20.2; p < 0.0001) while Escherichia notably declined during the same period (mean difference -11.2; p = 0.0064). At the operational taxonomic unit (OTU) level, there was a significantly higher level of overall richness in the pretreatment period than in the febrile neutropenic episode (mean OTU of 203.1 vs. 131.7; p = 0.012). Both of the diversity indexes of Shannon and Simpson showed a significant decrease during the febrile neutropenic period. Adult AML patients with a first episode of febrile neutropenia after initial intensive chemotherapy demonstrated a significant decrease in gut microbiota diversity and the level of diversity remained constant despite recovery of bone marrow.

摘要

发热性中性粒细胞减少症患者的肠道细菌菌群存在明显的多样性。然而,成人急性髓系白血病(AML)患者的相关改变报道较少。在诱导化疗开始前一天(预处理)、中性粒细胞减少性发热的第一天和骨髓恢复的第一天,采集每个初治 AML 患者的粪便样本。从粪便样本中提取细菌 DNA,并通过下一代测序对细菌 16s 核糖体 RNA 基因进行测序。计算相对丰度、总体丰富度、香农多样性指数和辛普森多样性指数。所有参与者均未进行抗生素预防。纳入了 10 例 AML 患者(4 例男性和 6 例女性),中位年龄为 39 岁(范围:19-49),所有患者均发生发热性中性粒细胞减少症。在中性粒细胞减少性发热期间,厚壁菌门占主导地位,随后在骨髓恢复后下降,与拟杆菌门和变形菌门的模式相反。与预处理相比,肠球菌在发热性中性粒细胞减少症期间更为丰富(平均差异+20.2;p<0.0001),而大肠杆菌在同一时期明显减少(平均差异-11.2;p=0.0064)。在操作分类单元(OTU)水平,预处理期的总体丰富度明显高于发热性中性粒细胞减少期(预处理期平均 OTU 为 203.1,发热性中性粒细胞减少期为 131.7;p=0.012)。Shannon 和 Simpson 的多样性指数在发热性中性粒细胞减少期间均显著下降。初始强化化疗后首次发生发热性中性粒细胞减少症的成人 AML 患者,肠道微生物多样性显著下降,尽管骨髓恢复,但多样性水平保持不变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dc5/7592783/6255b8d16192/pone.0236460.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dc5/7592783/1b1125730b60/pone.0236460.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dc5/7592783/d164f2414754/pone.0236460.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dc5/7592783/24c23d84801a/pone.0236460.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dc5/7592783/8e1a50b10110/pone.0236460.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dc5/7592783/cc1c2542b938/pone.0236460.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dc5/7592783/6255b8d16192/pone.0236460.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dc5/7592783/1b1125730b60/pone.0236460.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dc5/7592783/d164f2414754/pone.0236460.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dc5/7592783/24c23d84801a/pone.0236460.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dc5/7592783/8e1a50b10110/pone.0236460.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dc5/7592783/cc1c2542b938/pone.0236460.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dc5/7592783/6255b8d16192/pone.0236460.g006.jpg

相似文献

1
Gut microbiota profiles of treatment-naïve adult acute myeloid leukemia patients with neutropenic fever during intensive chemotherapy.未经过治疗的成人急性髓系白血病伴中性粒细胞减少症发热患者强化化疗期间的肠道微生物群特征。
PLoS One. 2020 Oct 28;15(10):e0236460. doi: 10.1371/journal.pone.0236460. eCollection 2020.
2
Prophylaxis of neutropenic fever with ciprofloxacin in patients with acute myeloid leukemia treated with intensive chemotherapy.环丙沙星对接受强化化疗的急性髓系白血病患者中性粒细胞减少性发热的预防作用
Asia Pac J Clin Oncol. 2016 Mar;12(1):e11-5. doi: 10.1111/ajco.12133. Epub 2013 Oct 17.
3
The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia.胃肠道微生物群在急性髓系白血病诱导化疗期间感染性并发症中的作用。
Cancer. 2016 Jul 15;122(14):2186-96. doi: 10.1002/cncr.30039. Epub 2016 May 3.
4
c-D-index at day 11 can predict febrile neutropenia during chemotherapy in acute myeloid leukemia.第 11 天的 c-D 指数可预测急性髓细胞白血病化疗期间的发热性中性粒细胞减少症。
PLoS One. 2022 Mar 17;17(3):e0263623. doi: 10.1371/journal.pone.0263623. eCollection 2022.
5
Neutropenic enterocolitis in patients with FLT3 mutated acute myeloid leukemia undergoing induction chemotherapy with midostaurin.接受米哚妥林诱导化疗的FLT3突变急性髓系白血病患者的中性粒细胞减少性小肠结肠炎
Int J Hematol. 2019 Mar;109(3):351-355. doi: 10.1007/s12185-018-2558-4. Epub 2018 Dec 3.
6
The expression of Toll-like receptors and development of severe sepsis in patients with acute myeloid leukemias after induction chemotherapy.急性髓系白血病患者诱导化疗后Toll样受体的表达与严重脓毒症的发生
Med Oncol. 2014 Dec;31(12):319. doi: 10.1007/s12032-014-0319-7. Epub 2014 Nov 22.
7
Effect of Linezolid on Hematologic Recovery in Newly Diagnosed Acute Myeloid Leukemia Patients Following Induction Chemotherapy.利奈唑胺对新诊断的急性髓系白血病患者诱导化疗后血液学恢复的影响。
Pharmacotherapy. 2016 Oct;36(10):1087-1094. doi: 10.1002/phar.1824. Epub 2016 Sep 20.
8
Miliaria-rash after neutropenic fever and induction chemotherapy for acute myelogenous leukemia.急性髓系白血病中性粒细胞减少性发热及诱导化疗后的粟丘疹皮疹
An Bras Dermatol. 2011 Jul-Aug;86(4 Suppl 1):S104-6. doi: 10.1590/s0365-05962011000700027.
9
Causative pathogens of fever in neutropenic patients at King Chulalongkorn Memorial Hospital.朱拉隆功国王纪念医院中性粒细胞减少患者发热的致病病原体
J Med Assoc Thai. 2010 Jul;93(7):776-83.
10
Continuous-monitoring blood culture screening system improves the detection of bacteremia in neutropenic patients.连续监测血培养筛查系统提高了中性粒细胞减少患者菌血症的检测率。
Scand J Infect Dis. 1996;28(3):287-92. doi: 10.3109/00365549609027175.

引用本文的文献

1
Characterization of Antibiotic Administration Factors Associated with Microbiome Disruption and Subsequent Antibiotic-Resistant Infection and Colonization Events in Acute Myeloid Leukemia Patients Receiving Chemotherapy.接受化疗的急性髓系白血病患者中与微生物群破坏及随后的抗生素耐药性感染和定植事件相关的抗生素给药因素的特征分析
Antibiotics (Basel). 2025 Jul 30;14(8):770. doi: 10.3390/antibiotics14080770.
2
Microbial Crosstalk with Therapy: Pharmacomicrobiomics in AML-One Step Closer to Personalized Medicine.微生物与治疗的相互作用:急性髓系白血病中的药物微生物组学——向个性化医疗迈进了一步
Biomedicines. 2025 Jul 18;13(7):1761. doi: 10.3390/biomedicines13071761.
3

本文引用的文献

1
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation.肠道菌群作为异基因造血细胞移植患者死亡的预测因子。
N Engl J Med. 2020 Feb 27;382(9):822-834. doi: 10.1056/NEJMoa1900623.
2
Microbiome Anomalies in Allogeneic Hematopoietic Cell Transplantation.异基因造血细胞移植中的微生物组异常。
Annu Rev Med. 2020 Jan 27;71:137-148. doi: 10.1146/annurev-med-052918-122440.
3
The Microbiota in Hematologic Malignancies.血液恶性肿瘤中的微生物群。
Unravelling neutropenic enterocolitis: insights from gut microbiota, and intestinal barrier analyses.
解析中性粒细胞减少性小肠结肠炎:来自肠道微生物群和肠道屏障分析的见解
Exp Hematol Oncol. 2025 May 16;14(1):74. doi: 10.1186/s40164-025-00661-4.
4
The Role of CPX-351 in the Acute Myeloid Leukemia Treatment Landscape: Mechanism of Action, Efficacy, and Safety.CPX-351在急性髓系白血病治疗格局中的作用:作用机制、疗效与安全性
Drugs. 2025 May 10. doi: 10.1007/s40265-025-02194-w.
5
Significant changes in gut microbiota and SCFAs among patients with newly diagnosed acute myeloid leukemia.新诊断急性髓系白血病患者肠道微生物群和短链脂肪酸的显著变化。
Front Microbiol. 2025 Apr 1;16:1559033. doi: 10.3389/fmicb.2025.1559033. eCollection 2025.
6
Mortality, loss to follow-up and advanced HIV disease following virologic success in West African HIV-2 patients.西非HIV-2患者病毒学成功后的死亡率、失访率及晚期HIV疾病情况。
PLoS One. 2025 Apr 2;20(4):e0317223. doi: 10.1371/journal.pone.0317223. eCollection 2025.
7
Gut Microbiome as a Potential Marker of Hematologic Recovery Following Induction Therapy in Acute Myeloid Leukemia Patients.肠道微生物群作为急性髓系白血病患者诱导治疗后血液学恢复的潜在标志物。
Cancer Med. 2025 Feb;14(3):e70501. doi: 10.1002/cam4.70501.
8
A View of Myeloid Transformation through the Hallmarks of Cancer.从癌症的特征看骨髓转化。
Blood Cancer Discov. 2024 Nov 1;5(6):377-387. doi: 10.1158/2643-3230.BCD-24-0009.
9
Causal Relationship Between Gut Microbiota and Leukemia: Future Perspectives.肠道微生物群与白血病之间的因果关系:未来展望
Oncol Ther. 2024 Dec;12(4):663-683. doi: 10.1007/s40487-024-00300-8. Epub 2024 Sep 1.
10
Gut microbiota plays pivotal roles in benign and malignant hematopoiesis.肠道微生物群在良性和恶性造血过程中发挥着关键作用。
Blood Sci. 2024 Jul 17;6(4):e00200. doi: 10.1097/BS9.0000000000000200. eCollection 2024 Oct.
Curr Treat Options Oncol. 2020 Jan 11;21(1):2. doi: 10.1007/s11864-019-0693-7.
4
Gut dysbiosis during antileukemia chemotherapy versus allogeneic hematopoietic cell transplantation.抗白血病化疗与异基因造血细胞移植期间的肠道菌群失调。
Cancer. 2020 Apr 1;126(7):1434-1447. doi: 10.1002/cncr.32641. Epub 2019 Dec 24.
5
Infectious Complications Are Associated With Alterations in the Gut Microbiome in Pediatric Patients With Acute Lymphoblastic Leukemia.感染并发症与急性淋巴细胞白血病儿科患者肠道微生物组的改变有关。
Front Cell Infect Microbiol. 2019 Feb 19;9:28. doi: 10.3389/fcimb.2019.00028. eCollection 2019.
6
The influence of ethnicity and geography on human gut microbiome composition.种族和地理位置对人类肠道微生物群组成的影响。
Nat Med. 2018 Oct;24(10):1495-1496. doi: 10.1038/s41591-018-0210-8.
7
FastQ Screen: A tool for multi-genome mapping and quality control.FastQ Screen:一种用于多基因组比对和质量控制的工具。
F1000Res. 2018 Aug 24;7:1338. doi: 10.12688/f1000research.15931.2. eCollection 2018.
8
Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography.描绘具有不同种族起源但具有相同地理位置的人群的肠道微生物群落组成。
Nat Med. 2018 Oct;24(10):1526-1531. doi: 10.1038/s41591-018-0160-1. Epub 2018 Aug 27.
9
Regional variation limits applications of healthy gut microbiome reference ranges and disease models.区域差异限制了健康肠道微生物群参考范围和疾病模型的应用。
Nat Med. 2018 Oct;24(10):1532-1535. doi: 10.1038/s41591-018-0164-x. Epub 2018 Aug 27.
10
Detrimental Effect of Broad-spectrum Antibiotics on Intestinal Microbiome Diversity in Patients After Allogeneic Stem Cell Transplantation: Lack of Commensal Sparing Antibiotics.异基因造血干细胞移植后广谱抗生素对肠道微生物多样性的有害影响:缺乏共生保护抗生素。
Clin Infect Dis. 2019 Apr 8;68(8):1303-1310. doi: 10.1093/cid/ciy711.